PA
INTR icon

PharVision Advisers’s Inter&Co INTR Stock Holding History

PharVision Advisers’s Portfolio INTR Stock Details INTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.8K Buy
+17,652
New +$119K 1.81% 22

Other funds holding INTR

SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SI
Squadra Investments Rio De Janeiro, Brazil $815M AUM 15.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $832M AUM 5.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PharVision Advisers's INTR Position: Q2 2026 in Review

PharVision Advisers opened a new position in Inter&Co (INTR) in Q2 2026: 17,652 shares worth $95.8K. The stake represents 1.81% of the portfolio and ranks #22 among its holdings.

137 funds tracked by Wall St. Rank hold INTR as of Q2 2026.

  • PharVision Advisers held 17,652 shares of Inter&Co worth $95.8K as of Q2 2026.
  • Inter&Co was a new PharVision Advisers position in Q2 2026.
  • Inter&Co made up 1.81% of PharVision Advisers's portfolio in Q2 2026, its #22 holding.
  • 137 funds tracked by Wall St. Rank held Inter&Co as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.